These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 26011302)

  • 21. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
    Klein M; Iazzettii L; Speiser P; Carey D; Shelov S; Accacha S; Fennoy I; Rosenbaum M; Rapaport R
    J Diabetes; 2015 Sep; 7(5):649-56. PubMed ID: 25266069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
    Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
    Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation.
    Al-Daghri NM; Al-Attas OS; Alokail M; Alkharfy K; Wani K; Amer OE; Ul Haq S; Rahman S; Alnaami AM; Livadas S; Kollias A; Charalampidis P; Sabico S
    Pediatr Res; 2014 Mar; 75(3):459-63. PubMed ID: 24296798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
    Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
    Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
    Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
    Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
    Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.
    Jamali R; Razavizade M; Arj A; Aarabi MH
    World J Gastroenterol; 2016 Jun; 22(21):5096-103. PubMed ID: 27275102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
    Hernández MJG; Klünder M; Nieto NG; Alvarenga JCL; Gil JV; Huerta SF; Siccha RQ; Hernandez J
    Endocr Pract; 2018 Mar; 24(3):294-301. PubMed ID: 29547047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
    Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
    Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
    Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
    Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
    [No Abstract]   [Full Text] [Related]  

  • 39. Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?
    Ebrahimi R; Shanaki M; Mohassel Azadi S; Bahiraee A; Radmard AR; Poustchi H; Emamgholipour S
    Arch Physiol Biochem; 2022 Feb; 128(1):24-31. PubMed ID: 31482741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study.
    Li Q; Wang L; Wu J; Wang J; Wang Y; Zeng X
    BMJ Open; 2022 Mar; 12(3):e058517. PubMed ID: 35314476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.